Claritev Income from Continuous Operations 2019-2025 | CTEV

Claritev income from continuous operations from 2019 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Claritev Annual Income from Continuous Operations
(Millions of US $)
2024 $-1,646
2023 $-92
2022 $-573
2021 $102
2020 $-521
2019 $10
2018 $36
Claritev Quarterly Income from Continuous Operations
(Millions of US $)
2025-03-31 $-71
2024-12-31 $-138
2024-09-30 $-391
2024-06-30 $-577
2024-03-31 $-540
2023-12-31 $-31
2023-09-30 $-24
2023-06-30 $-36
2023-03-31 $0
2022-12-31 $-650
2022-09-30 $20
2022-06-30 $14
2022-03-31 $44
2021-12-31 $25
2021-09-30 $78
2021-06-30 $-47
2021-03-31 $46
2020-12-31 $-173
2020-09-30 $-288
2020-06-30 $-56
2020-03-31 $-3
2019-12-31
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.742B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.059B 59.87
Doximity (DOCS) United States $11.521B 53.34
Hims & Hers Health (HIMS) United States $11.158B 115.93
Tempus AI (TEM) United States $11.000B 0.00
IRhythm Technologies (IRTC) United States $4.915B 0.00
Hinge Health (HNGE) United States $4.037B 0.00
Inspire Medical Systems (INSP) United States $3.827B 59.80
Privia Health (PRVA) United States $2.804B 191.67
Enovis (ENOV) United States $1.791B 9.99
Phreesia (PHR) United States $1.693B 0.00
Schrodinger (SDGR) United States $1.476B 0.00
10x Genomics (TXG) United States $1.426B 0.00
Clover Health Investments (CLOV) United States $1.420B 0.00
Azenta (AZTA) United States $1.409B 65.49
Omnicell (OMCL) United States $1.377B 24.30
Evolent Health (EVH) United States $1.322B 112.60
Fulgent Genetics (FLGT) United States $0.605B 0.00
Veradigm (MDRX) United States $0.509B 0.00
Butterfly Network (BFLY) United States $0.495B 0.00
Talkspace (TALK) United States $0.465B 139.00
Standard BioTools (LAB) United States $0.456B 0.00
TruBridge (TBRG) United States $0.352B 780.67
Outset Medical (OM) United States $0.340B 0.00
Health Catalyst (HCAT) United States $0.262B 0.00
Nyxoah SA (NYXH) Belgium $0.255B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.207B 0.00
KORU Medical Systems (KRMD) United States $0.165B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.133B 0.00
MDxHealth SA (MDXH) Belgium $0.105B 0.00
Pulmonx (LUNG) United States $0.104B 0.00
CareCloud (CCLD) United States $0.100B 3.81
Insight Molecular Diagnostics (IMDX) United States $0.086B 0.00
111 (YI) China $0.062B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.049B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.039B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00